ArticleBMJ public health2026
Late-life depression and risk of all-cause and cause-specific mortality in an Asian population: the Singapore Chinese Health Study.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Introduction: Although late-life depressive symptoms were associated with mortality risk, their relationship with cause-specific mortality remained unclear. Hence, we investigated these in older Chinese adults living in Singapore. Methods: We used data from 16 782 participants aged 61-96 years from follow-up 3 (2014-2016) of the Singapore Chinese Health Study. Depressive symptoms were defined as having ≥5 symptoms on the 15-item Geriatric Depression Scale. Mortality data were obtained through linkage with nation-wide death registry till 31 December 2022. We used Cox proportional hazard models and competing risk regression models to estimate HRs and 95% CIs for association with mortalities. Results: After a mean follow-up of 6.9 years, there were 2 960 deaths. Depressive symptoms were significantly associated with total and cause-specific mortality; the multivariable-adjusted HRs (95% CIs) were 1.20 (1.11 to 1.30), 1.38 (1.14 to 1.67), 1.41 (1.16 to 1.70) and 1.91 (1.13 to 3.21) for mortalities from all causes, ischaemic heart disease (IHD), infectious respiratory diseases and chronic, non-malignant respiratory diseases, respectively. The associations were stronger among smokers for all-cause mortality (HR (95% CI) 1.55 (1.25 to 1.92) vs 1.15 (1.05 to 1.26) in non-smokers; Conclusions: Late-life depressive symptoms were associated with increased risk of all-cause, IHD and respiratory disease mortalities. The associations were stronger among those <75 years old and smokers, highlighting the importance of screening for and addressing depressive symptoms in these at-risk groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.